Wenqun Li

10PUBLICATIONS
15CO-AUTHORS
Pharmaceutical delivery technologiesCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCellular nervous systemMolecular medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Feb 25, 2026
Old Drug, New Opportunity: Drug Repurposing in Cardiovascular Diseases.

Xiuyi Ou, Sa Liu, Pengcheng Sun

|Mar 24, 2025
Oridonin Alleviates Doxorubicin-Induced Cardiotoxicity by Inhibiting p38 MAPK/MMP3 Signaling Pathway.

Xingyuan Hou, Suifen Xie, Ni Zhou

|Jan 14, 2025
Novel Protective Role for Gut Microbiota-derived Metabolite PAGln in Doxorubicin-induced Cardiotoxicity.

Jie Huang, Xingyuan Hou, Ni Zhou

|May 29, 2023
Hyperoside prevents doxorubicin-induced cardiotoxicity by inhibiting NOXs/ROS/NLRP3 inflammasome signaling pathway.

Shanshan Wei, Wanjun Ma, Chuanhao Jiang

|May 20, 2022
Noncoding RNA-Associated Competing Endogenous RNA Networks in Doxorubicin-Induced Cardiotoxicity.

Zijun Xiao, Shanshan Wei, Jie Huang

|Dec 19, 2021
Disulfiram attenuates lipopolysaccharide-induced acute kidney injury by suppressing oxidative stress and NLRP3 inflammasome activation in mice.

Jie Huang, Shanshan Wei, Zhenyu Peng

Pageof 2

Frequent Collaborators

2 joint publications

Bikui Zhang

2 joint publications

Rong Yu

2 joint publications

Jianhua Huang

2 joint publications

Wanjun Ma